#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14488	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2115	678.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	827	C	809	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	823	C,T,G	792,7,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1666	1666	A	906	A,G	879,7	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	804	C	784	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	823	A	805	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	840	C,T	816,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3594	739.8	0	HET	.	.	.	A239C,G	.	239	239	A	568	568	A	887	A,C,G	653,199,1	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	298	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1423	20.8	0	.	p	.	0	M180T	NONSYN	538	540	ATG	742	744	ACG	35;35;35	A;C;G	31;33;33	.	Betalactam resistance
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	V36A	NONSYN	106	108	GTG	392	394	GCG	160;160;161	G;C;G	157;157;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	434	436	CGG	154;156;157	C;G,T;G,T	149;150,1;151,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	S68L	NONSYN	202	204	TCG	488	490	TTG	140;136;140	T;T;G	130;134;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	A90V	NONSYN	268	270	GCG	554	556	GTT	152;149;146	G;T,C,G;T,G	145;135,1,1;142,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	I105V	NONSYN	313	315	ATT	599	601	GTT	163;163;161	G;T,G;T	157;150,1;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	N125T	NONSYN	373	375	AAT	659	661	ACC	164;161;161	A;C;C	155;152;156	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	R135C	NONSYN	403	405	CGT	689	691	TGT	179;178;178	T,C;G;T,C,G	161,3;170;159,2,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	K151E	NONSYN	451	453	AAA	737	739	GAA	155;158;158	G;A;A	153;156;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	740	742	AAC	160;162;162	A,G;A;C	157,2;162;161	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	A172T	NONSYN	514	516	GCG	800	802	ACA	135;137;136	A;C;A	133;136;133	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	A175E	NONSYN	523	525	GCG	809	811	GAA	134;136;141	G;A;A	134;136;139	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	E176T	NONSYN	526	528	GAA	812	814	ACC	145;146;144	A;C;C	139;146;144	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	I178V	NONSYN	532	534	ATC	818	820	GTC	146;146;147	G;T;C	144;144;145	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	I188T	NONSYN	562	564	ATA	848	850	ACG	143;146;145	A;C;G	138;142;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	P200N	NONSYN	598	600	CCC	884	886	AAC	129;129;131	A;A,C;C	126;121,1;127	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	F220L	NONSYN	658	660	TTT	944	946	TTG	133;133;133	T;T;G	129;132;132	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1001	1003	ACC	114;114;114	A;C;C	107;110;108	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1004	1006	GAC	120;119;119	G;A;C	116;111;115	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1013	1015	GCG	119;117;115	G;C,A,G;G	114;91,1,1;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1049	1051	GCT	110;109;108	G,T;C;T,C	104,4;104;99,4	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1502	folP	858	858	91.61	folP.l15.c4.ctg.1	1464	101.9	1	SNP	p	R230S	1	.	.	688	690	AGC	974	976	AGC	132;131;131	A;G;C	130;129;129	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	144.9	1	SNP	p	S91F	0	.	.	271	273	TCC	635	637	TCC	191;191;191	T;C;C	182;184;184	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	144.9	1	SNP	p	D95G	0	.	.	283	285	GAC	647	649	GAC	180;178;175	G;A;C	176;170;171	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4986	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	144.9	1	SNP	p	D95N	0	.	.	283	285	GAC	647	649	GAC	180;178;175	G;A;C	176;170;171	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1578	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1264	124.0	1	SNP	p	G45D	1	.	.	133	135	GAC	399	401	GAC	175;174;175	G;A,G;C	169;165,2;169	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	872	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	985	87.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2920	158.6	1	SNP	p	D86N	0	.	.	256	258	GAC	566	568	GAC	157;157;159	G;A;C	153;151;156	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2920	158.6	1	SNP	p	S87I	0	.	.	259	261	AGT	569	571	AGT	160;163;167	A,G;G;T	152,1;159;154	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2920	158.6	1	SNP	p	S87R	0	.	.	259	261	AGT	569	571	AGT	160;163;167	A,G;G;T	152,1;159;154	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2920	158.6	1	SNP	p	S87W	0	.	.	259	261	AGT	569	571	AGT	160;163;167	A,G;G;T	152,1;159;154	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2920	158.6	1	SNP	p	S88P	0	.	.	262	264	TCC	572	574	TCC	166;167;169	T;C;C	161;160;164	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3754	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2637	141.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1541	1543	GGC	189;187;189	G;G;C	183;182;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1202	1204	GCC	213;212;213	G;C;C	207;207;205	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1205	1207	ATG	218;216;220	A;T;G	210;208;210	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1217	1219	ACC	223;224;225	A;C;C	207;217;216	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1217	1219	ACC	223;224;225	A;C;C	207;217;216	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1718	1720	ACC	195;195;199	A;C;C,A	186;188;190,2	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1772	1774	GCG	191;189;190	G;C,G;G	180;183,1;183	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1772	1774	GCG	191;189;190	G;C,G;G	180;183,1;183	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1895	1897	GGT	151;150;149	G;G;T,C	147;146;137,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1904	1906	AGC	142;140;138	A,G;G;C	137,2;137;134	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2363	164.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1922	1924	CCG	113;112;109	C,G;C,G;G,C	103,1;102,3;89,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5594	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3142	176.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2298	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1723	131.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	546	546	C	175	C,G	160,2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	100	102	TTA	53;53;53	T;T;A	49;52;51	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	145	147	CAT	50;50;49	C;A;T	48;46;47	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	148	150	AGT	47;47;47	A;G;T	47;47;47	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	157	159	TAC	47;47;48	T;A;C	47;47;48	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	247	249	GAA	18;18;19	G;A;A	18;18;19	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	259	261	GCA	19;19;20	G;C;A	19;19;20	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	268	270	ATC	18;18;19	A;T;C	18;18;18	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	274	276	TCG	17;17;18	T;C;G	16;16;18	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	280	282	GCC	17;17;18	G;C;C	17;17;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	283	285	AGC	18;18;18	A;G;C	17;17;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	286	288	GCC	16;16;16	G;C;C	15;16;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	271	92.25	porB1a.l15.c30.ctg.1	388	30.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	292	294	GTT	16;16;16	G;T;T	15;16;16	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1570	176.4	0	.	p	.	0	E41K	NONSYN	121	123	GAA	530	532	AAA	217;220;222	A,G;A;A	210,1;216;218	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1570	176.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1040	1040	T	217	T	204	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1570	176.4	1	SNP	p	G120K	0	.	.	358	360	GGT	767	769	GGT	215;213;213	G,A,T;G,A;T,C,G	209,2,1;208,2;199,4,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1570	176.4	1	SNP	p	A121D	0	.	.	361	363	GCC	770	772	GCC	210;209;210	G,A,T;C,A;C	204,2,1;204,2;208	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1570	176.4	1	SNP	p	A121N	0	.	.	361	363	GCC	770	772	GCC	210;209;210	G,A,T;C,A;C	204,2,1;204,2;208	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9876	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4805	204.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1946	1948	CAT	228;229;231	C,A;A;T	222,1;225;225	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1094	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1110	98.0	1	SNP	p	V57M	1	.	.	169	171	ATG	584	586	ATG	219;221;220	A;T;G	213;217;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
